
Loading, please wait...

Loading, please wait...

Atopic dermatitis (AD) is a chronic inflammatory skin condition that significantly impacts the quality of life in young patients. While physicians often associate the disease with mood and anxiety disorders, the actual atopic dermatitis psychiatric burden leading to inpatient care has been less clear. A recently published study by Patel S et al. (2026) addressed this gap by reviewing the 2022 Kids' Inpatient Database to determine if adolescents with AD are more likely to be hospitalized for psychiatric reasons.
The research team identified 1,520 adolescent patients with atopic dermatitis and propensity-matched them with 7,634 controls. The primary objective was to assess if their reason for hospital admission was psychiatric. This category encompassed various conditions, including mood disorders, suicidal ideation, psychotic disorders, and eating disorders. Interestingly, psychiatric reasons accounted for 24.1% of admissions in the AD group, compared to 26.6% in the control group. The difference was not statistically significant (p = 0.2).
Furthermore, the multivariate analysis demonstrated that patients with AD did not have significantly higher odds of being admitted for psychiatric reasons compared to the control group. The adjusted Odds Ratio (aOR) stood at 0.87 (95% CI: 0.72-1.05). These results suggest that while the atopic dermatitis psychiatric burden may lead to psychological distress, it does not necessarily translate into severe disease progression requiring hospitalization in the adolescent demographic.
Although the risk of hospitalization may not be elevated, clinicians must remain vigilant regarding the mental health of their patients. Adolescence is a critical period for identity formation, and visible skin lesions can exacerbate social anxiety and depression. Therefore, dermatologists and pediatricians should incorporate routine mental health screenings into their practice. Effective management of pruritus and inflammation is essential to improving sleep and reducing psychological strain. In India, where stigmatization of skin conditions remains prevalent, patient counseling becomes even more vital for holistic care.
According to the latest research, adolescents with atopic dermatitis do not have significantly higher odds of being hospitalized for psychiatric reasons compared to those without the condition. However, they still face a higher risk of outpatient mental health challenges.
Common comorbidities include anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and sleep disturbances. While these may not always lead to hospitalization, they significantly impact daily functioning and quality of life.
Yes, experts recommend integrated care. Screening for psychological distress is crucial, as the chronic nature of eczema and social factors can lead to significant emotional burden even if hospitalization is not required.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship between the reader and the author. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Patel S et al. Inpatient Psychiatric Burden in Adolescents With Atopic Dermatitis. Pediatr Dermatol. 2026 Feb 22. doi: 10.1111/pde.70165. PMID: 41723878.
Handa S et al. Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus. Dove Med Press. 2021 Nov 22.
Wan J et al. Severe Atopic Dermatitis Associated with Depression in Pediatric Patients. JAAD. 2021 Sep 02.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study assessing whether atopic dermatitis increases the risk of psychiatric hospitalization among adolescents, finding no significant difference in odds....
8 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today